![Nia Tatsis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nia Tatsis
Direktor/Vorstandsmitglied bei
VERTEX PHARMACEUTICALS INCORPORATED
Vermögen: 23 Mio $ am 30.06.2026
Profil
Nia Tatsis currently serves as Chief Regulatory & Quality Officer, Director, EVP at Vertex Pharmaceuticals, Inc. since 2025, Independent Director at Odyssey Therapeutics, Inc. since 2025, and Member-Leadership Council at the International Institute of New England since 2021.
Former roles include Director at Verve Therapeutics, Inc. from 2024 to 2025 and Vice President & Head-Global Regulatory Affairs at Genzyme Corp.
from 2014 to 2017.
Education includes undergraduate studies at Temple University (Pennsylvania) and a doctorate from the University of Vermont.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.07.2026 | 45’321 ( 0.02% ) | 23 Mio $ | 30.06.2026 |
Aktive Positionen von Nia Tatsis
| Unternehmen | Position | Beginn |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Direktor/Vorstandsmitglied | 10.10.2025 |
| ODYSSEY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.09.2025 |
International Institute of New England
 International Institute of New England Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for immigration and foreign communities | Corporate Officer/Principal | 01.01.2021 |
Ehemalige bekannte Positionen von Nia Tatsis
| Unternehmen | Position | Ende |
|---|---|---|
| VERE THER | Direktor/Vorstandsmitglied | 25.07.2025 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01.01.2017 |
Ausbildung von Nia Tatsis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
42
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute of New England
International Institute of New England Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for immigration and foreign communities | Commercial Services |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases | Health Technology |
Wählen Sie MarketScreener 
